Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseasesRamya Ramaswami, Robert Yarchoan, Priscila Gonçalves et al.|Blood Advances|2021Cited by 78
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphomaKathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 69
Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion LymphomaKrithika Shanmugasundaram, Kathryn Lurain, Ramya Ramaswami et al.|Blood|2021Cited by 7
Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphomaKathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Haematologica|2022Cited by 6
Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)Kathryn Lurain, Robert Yarchoan, Ramya Ramaswami et al.|Blood|2020Cited by 5